Loading company…
Riskpilot
← Back to search
Sign in
Get full access
EQUITERAPI MIDT-NORGE AS
AS
Active
Org 988132497
Dyvasvegen 652, 7517 Hell
Support activities for animal production · NACE 0162
Est. 2005
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 604K
-30% vs 2024
EBITDA margin
9.3%
+204% vs 2024
Equity ratio
-107.0%
Financial strength
Net profit 2025
NOK 48K
+188% vs 2024
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 604K
-30%
EBITDA
NOK 56K
+204%
Net profit
NOK 48K
+188%
Total assets
NOK 82K
+3%
Equity
NOK -88K
+36%
Employees
1
—
Company information
Legal name
EQUITERAPI MIDT-NORGE AS
Org number
988132497
Legal form
Aksjeselskap
NACE code
0162 · Support activities for animal production
Founded
26. april 2005
Share capital
NOK 400 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og daglig leder hver for seg.
Company purpose
Tjenester tilknyttet hestehold. Å drive behandling og rehabilitering av hovedsaklig hester. Alternativ behandling av hester.
Contact
Address
Dyvasvegen 652, 7517 Hell
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Support activities for animal production
Companies in Stjørdal
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
958
772
510
861
604
Staff expenses
−484
−302
−275
−418
−187
EBITDA
173
107
−148
−54
56
Depreciation & amort.
−12
−10
−8
−1
−8
EBIT
161
97
−156
−55
48
Net financials
−5
−3
0
−0
0
Profit before tax
156
94
−156
−55
48
Tax
−0
−0
−0
−0
−0
Net profit
156
94
−156
−55
48
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
201
207
127
80
82
Equity
−22
73
−81
−136
−88
Long-term debt
53
0
0
0
0
Short-term debt
169
134
208
216
170
Total debt
222
134
208
216
170
Financial ratios
5-year trend
EBITDA margin
9.3%
This company
15.8%
Market median
-41% vs market
2021
2025
Equity ratio
-107.0%
This company
38.2%
Market median
-380% vs market
2021
2025
Return on equity
4835000.0%
This company
18.4%
Market median
+26277074% vs market
2021
2025
Net profit margin
8.0%
This company
8.1%
Market median
-1% vs market
2021
2025
Asset turnover
7.37×
This company
1.12×
Market median
+558% vs market
2021
2025
Debt / equity
1.93×
This company
0.62×
Market median
-211% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MJ
Marit Johanne Sæther Draveng
Chief Executive Officer
Chief Executive Officer
2005
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
TS
Terje Sæther
Chairman
2005
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Unknown
Individual
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of EQUITERAPI MIDT-NORGE AS also hold positions in
0
other companies.
Person
Role here
Other companies
Marit Johanne Sæther Draveng
Chief Executive Officer
0 companies
Terje Sæther
Chairman
0 companies